Proteomic studies on apoB‐containing lipoprotein in cardiovascular research: A comprehensive review

E Gianazza, B Zoanni, A Mallia… - Mass Spectrometry …, 2023 - Wiley Online Library
The complexity of cardiovascular diseases (CVDs), which remains the leading cause of
death worldwide, makes the current clinical pathway for cardiovascular risk assessment …
被引用次数：5 相关文章

Proteomic studies on apoB-containing lipoprotein in cardiovascular research: A comprehensive review.

E Gianazza, B Zoanni, A Mallia, M Brioschi… - Mass Spectrometry …, 2021 - europepmc.org
The complexity of cardiovascular diseases (CVDs), which remains the leading cause of
death worldwide, makes the current clinical pathway for cardiovascular risk assessment …
[PDF] archive.org

[PDF][PDF] Proteomic studies on apoB‐containing lipoprotein in cardiovascular research: A comprehensive review

E Gianazza, B Zoanni, A Mallia, M Brioschi… - 2021 - scholar.archive.org
The complexity of cardiovascular diseases (CVDs), which remains the leading cause of
death worldwide, makes the current clinical pathway for cardiovascular risk assessment …

Proteomic studies on apoB-containing lipoprotein in cardiovascular research: A comprehensive review

E Gianazza, B Zoanni, A Mallia, M Brioschi… - MASS …, 2021 - boa.unimib.it
The complexity of cardiovascular diseases (CVDs), which remains the leading cause of
death worldwide, makes the current clinical pathway for cardiovascular risk assessment …

[引用][C] Proteomic studies on apoB‑containing lipoprotein in cardiovascular research: A comprehensive review

E Gianazza, B Zoanni, A Mallia… - Mass Spectrometry …, 2023 - ui.adsabs.harvard.edu
Proteomic studies on apoB‑containing lipoprotein in cardiovascular research: A comprehensive
review - NASA/ADS Now on home page ads icon ads Enable full ADS view NASA/ADS …

Proteomic studies on apoB-containing lipoprotein in cardiovascular research: A comprehensive review

E Gianazza, B Zoanni, A Mallia… - Mass …, 2023 - pubmed.ncbi.nlm.nih.gov
The complexity of cardiovascular diseases (CVDs), which remains the leading cause of
death worldwide, makes the current clinical pathway for cardiovascular risk assessment …